金吾财讯 | 礼来(LLY)股价向好,截至发稿,涨2.06%,报859.5美元,成交额10.44亿美元。在热销的糖尿病和肥胖症治疗药物的推动下,礼来公司第四季度利润翻了一番,而且该制药商发布的 2025 年预测也好于预期。礼来最畅销的产品糖尿病治疗药物 Mounjaro 的销售额在 2024 年最后一个季度增长了 60%,达到 35.3 亿美元,而其肥胖症治疗药物 Zepbound 的销售额则达到...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.